No, that's not at all what we're thinking.
What we'd be doing is exactly what was done with Canada's Ebola vaccine, where phase one and two studies were done and then phase three studies and an emergency authorization were used, and that stopped the epidemic in west Africa. In fact, that vaccine, which was ultimately being developed by Merck, only received licensure, full market authorization, about a year and a half ago, four years after it stopped the epidemic in west Africa.
Emergency authorization is one of the tools Health Canada has as well, and may be something that may be used for a promising vaccine, no matter who the manufacturer is. That's done in a perfectly ethical manner.